25 years of contrast-enhanced MRI: developments, current challenges and future perspectives
J Lohrke, T Frenzel, J Endrikat, FC Alves, TM Grist… - Advances in …, 2016 - Springer
In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …
Imaging of the radiographically dense breast.
VP Jackson, RE Hendrick, SA Feig, DB Kopans - Radiology, 1993 - pubs.rsna.org
Despite recent improvements in mammography equipment and technique, the
radiographically dense breast remains difficult to image. The problems in imaging the dense …
radiographically dense breast remains difficult to image. The problems in imaging the dense …
Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI
We describe a novel imaging technique that yields all of the observable properties of the
binary spin‐bath model for magnetization transfer (MT) and demonstrate this method for in …
binary spin‐bath model for magnetization transfer (MT) and demonstrate this method for in …
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer
E Yeh, P Slanetz, DB Kopans… - American Journal of …, 2005 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to determine the relative accuracy of
mammography, sonography, and MRI in predicting residual tumor after neoadjuvant …
mammography, sonography, and MRI in predicting residual tumor after neoadjuvant …
Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
SG Orel, MD Schnall, VA LiVolsi, RH Troupin - Radiology, 1994 - pubs.rsna.org
PURPOSE: To study the architecture and enhancement characteristics of breast lesions with
magnetic resonance imaging. MATERIALS AND METHODS: Forty-one patients with …
magnetic resonance imaging. MATERIALS AND METHODS: Forty-one patients with …
Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging
L Esserman, N Hylton, L Yassa, J Barclay… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: The staging and treatment for breast cancer are changing; there is an increase
in the incidence of ductal carcinoma-in-situ, the use of fine-needle aspiration and …
in the incidence of ductal carcinoma-in-situ, the use of fine-needle aspiration and …
Magnetization transfer imaging: practical aspects and clinical applications.
SD Wolff, RS Balaban - Radiology, 1994 - pubs.rsna.org
Images whose contrast depends on this dipolar process may be obtained by using the
technique of magnetization transfer(MT) imaging, as first described by Wolff and Balaban(4) …
technique of magnetization transfer(MT) imaging, as first described by Wolff and Balaban(4) …
Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography
U Hoffmann, G Brix, MV Knopp, T Heβ… - Magnetic resonance …, 1995 - Wiley Online Library
A dynamic contrast‐enhanced MRI technique for whole breast examinations is presented.
The fast kinetics of tissue response during and after constant‐rate intravenous infusion of …
The fast kinetics of tissue response during and after constant‐rate intravenous infusion of …
Ductal carcinoma in situ: MR imaging-histopathologic correlation.
R Gilles, B Zafrani, JM Guinebretière, M Meunier… - Radiology, 1995 - pubs.rsna.org
PURPOSE: To correlate histopathologic and magnetic resonance (MR) imaging findings of
ductal carcinoma in situ (DCIS). MATERIALS AND METHODS: Thirty-six women with DCIS …
ductal carcinoma in situ (DCIS). MATERIALS AND METHODS: Thirty-six women with DCIS …
Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging
DC Abraham, RC Jones, SE Jones… - … Journal of the …, 1996 - Wiley Online Library
BACKGROUND The implementation of new treatment protocols for locally advanced breast
cancer is currently limited by inaccurate evaluation of response to neoadjuvant …
cancer is currently limited by inaccurate evaluation of response to neoadjuvant …